JPMorgan Healthcare Lead ETFJDOCETF
13F holders, Q3 2025 (September 30)7holders +1
1new positions
0sold out
$52.51avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding JPMorgan Healthcare Lead ETF (JDOC) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were JPMorgan Chase & Co. ($4.6M), Jane Street Group, LLC ($1.1M) and Krilogy Financial LLC ($325K).
- Company
- JPMorgan Healthcare Lead ETF
- CUSIP
- 46654Q765
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $325K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 7,244 shares bought and 1,279 shares sold, net +5,965 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| JPMorgan Chase & Co. | 0.00% | No change | 88,196 | $4.6M |
| Jane Street Group, LLC | 0.00% | Reduce -5.3% | 21,877 | $1.1M |
| Krilogy Financial LLC | 0.01% | New | 5,958 | $325K |
| Sanctuary Advisors, LLC | 0.00% | Add +17.3% | 5,641 | $296K |
| Ignite Planners, LLC | 0.03% | Reduce -1.5% | 3,995 | $209K |
| UBS Group AG | 0.00% | Add +462.2% | 551 | $29K |
| Royal Bank of Canada | 0.00% | No change | 120 | $6K |
"% of holder's portfolio" is JDOC's weight in each manager's 13F, not the share of JPMorgan Healthcare Lead ETF the manager owns.